日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis

使用BPaL治疗广泛耐药结核病的预算影响

期刊:Bmj Global Health
影响因子:6.1
doi:10.1136/bmjgh-2021-007182
Mulder, Christiaan; Rupert, Stephan; Setiawan, Ery; Mambetova, Elmira; Edo, Patience; Sugiharto, Jhon; Useni, Sani; Malhotra, Shelly; Cook-Scalise, Sarah; Pambudi, Imran; Kadyrov, Abdullaat; Lawanson, Adebola; van den Hof, Susan; Gebhard, Agnes; Juneja, Sandeep; Sohn, Hojoon
发表日期：2022
文献求助 收藏

Clinical Impact of Rapid Drug Susceptibility Testing to Accompany Fluoroquinolone-Containing Universal Tuberculosis Regimens: A Markov Model

快速药物敏感性检测在含氟喹诺酮类药物的通用结核病治疗方案中的临床影响：马尔可夫模型

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciz1179
Kendall, Emily A; Malhotra, Shelly; Cook-Scalise, Sarah; Dowdy, David W; Denkinger, Claudia M
发表日期：2020
文献求助 收藏

Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations

评估一种新型结核病治疗药物方案的影响：基于预测患者结果和流行病学因素的建模分析

期刊:BMC Infectious Diseases
影响因子:3
doi:10.1186/s12879-019-4429-x
Kendall, Emily A; Malhotra, Shelly; Cook-Scalise, Sarah; Denkinger, Claudia M; Dowdy, David W
发表日期：2019
文献求助 收藏